We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Eldorado Gold
EGO
$8.48B
| $7.08M | 0.02% |
1,173,400
-476,900
| -29% | -$2.8M |
|
602
Theravance Biopharma
TBPH
$874M
| $7.06M | 0.02% |
+696,600
| New | +$6.53M |
|
603
Regions Financial
RF
$26.2B
| $7.02M | 0.02% |
349,800
-72,800
| -17% | -$1.54M |
|
604
Genuine Parts
GPC
$17.6B
| $7.02M | 0.02% |
47,000
+9,800
| +26% | +$1.48M |
|
605
BlackBerry
BB
$4.93B
| $7.01M | 0.02% |
1,490,758
+896,201
| +151% | +$5.36M |
|
606
Iridium Communications
IRDM
$4.87B
| $6.99M | 0.02% |
157,500
+21,600
| +16% | +$936K |
|
607
STAAR Surgical
STAA
$1.14B
| $6.97M | 0.02% |
98,841
-41,300
| -29% | -$3.53M |
|
608
Digi International
DGII
$2.55B
| $6.97M | 0.02% |
201,611
+95,500
| +90% | +$2.96M |
|
|
CHNG
609
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $6.96M | 0.02% |
253,200
-1,031,700
| -80% | -$25.6M |
|
|
KREF
610
KKR Real Estate Finance Trust
KREF
$471M
| $6.9M | 0.02% |
424,500
-7,000
| -2% | -$132K |
|
611
Rocket Pharmaceuticals
RCKT
$355M
| $6.89M | 0.02% |
431,451
+78,800
| +22% | +$1.23M |
|
612
Cirrus Logic
CRUS
$6.87B
| $6.88M | 0.02% |
100,000
+64,200
| +179% | +$5.04M |
|
613
Marten Transport
MRTN
$1.26B
| $6.87M | 0.02% |
358,565
+74,300
| +26% | +$1.49M |
|
614
PJT Partners
PJT
$4.36B
| $6.86M | 0.02% |
102,600
-16,000
| -13% | -$1.12M |
|
615
Canadian Imperial Bank of Commerce
CM
$108B
| $6.83M | 0.02% |
156,200
+75,400
| +93% | +$3.67M |
|
|
MGI
616
DELISTED
MoneyGram International, Inc. New
MGI
| $6.82M | 0.02% |
656,147
-1,134,500
| -63% | -$11.7M |
|
617
Arcos Dorados Holdings
ARCO
$1.75B
| $6.8M | 0.02% |
932,734
+127,600
| +16% | +$919K |
|
618
SS&C Technologies
SSNC
$18.1B
| $6.78M | 0.02% |
141,900
-385,900
| -73% | -$22.2M |
|
619
Evolent Health
EVH
$429M
| $6.77M | 0.02% |
188,500
-13,000
| -6% | -$458K |
|
620
Four Corners Property Trust
FCPT
$2.83B
| $6.75M | 0.02% |
278,900
+45,100
| +19% | +$1.24M |
|
621
Lantheus
LNTH
$7.03B
| $6.74M | 0.02% |
95,800
-178,600
| -65% | -$13.5M |
|
622
Genworth Financial
GNW
$3.79B
| $6.69M | 0.02% |
1,910,900
+691,900
| +57% | +$2.79M |
|
623
TechTarget
TTGT
$275M
| $6.67M | 0.02% |
112,700
+38,500
| +52% | +$2.48M |
|
624
Harmonic Inc
HLIT
$1.23B
| $6.66M | 0.02% |
509,737
+481,600
| +1,712% | +$5.2M |
|
625
Vertex Pharmaceuticals
VRTX
$122B
| $6.66M | 0.02% |
23,000
-1,700
| -7% | -$489K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.